Terminal Lucidity in a Pediatric Oncology Clinic
Philip Roehrs1, Peter Fenwick2, Bruce Greyson1
1University of Virginia, Charlottesville, Virginia.
The Journal of Nervous and Mental Disease
|September 21, 2023
Summary
Terminal lucidity, or enhanced mental clarity before death, was observed in pediatric patients. These unexplained improvements in cognition and communication occurred shortly before death, challenging medical expectations.
Area of Science:
- Neurology
- Pediatrics
- Palliative Care
Background:
- Terminal lucidity is a documented phenomenon across cultures.
- It has been observed in patients with various neurological and psychiatric conditions, as well as terminal illnesses.
Purpose of the Study:
- To document clinical presentations of terminal lucidity in pediatric populations.
- To explore unexplained improvements in mental clarity and communication in children nearing death.
Main Methods:
- Purposive sampling through professional networks.
- Solicitation of clinical presentations from pediatric oncologists and medical personnel.
- Compilation of cases by attending physicians at two tertiary pediatric hospitals.
Main Results:
- Observed unanticipated changes in mental clarity, verbal communication, and physical capability in pediatric patients before death.
- These improvements were noted in the days and hours preceding death.
- The patients' medical conditions did not predict or explain these lucidity events.
Conclusions:
- The documented cases suggest the occurrence of terminal lucidity in children.
- Further systematic documentation and clinical research are necessary to draw definitive conclusions.
- Terminal lucidity offers a framework for understanding these observed deviations in pediatric end-of-life care.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:10Lucid Dreaming
156
Lucid dreaming is a unique state of consciousness where an individual realizes they are dreaming while still in the dream. This awareness allows them to manipulate their dream environment consciously. Researchers like Stephen LaBerge have significantly contributed to the understanding of lucid dreams, highlighting that during these dreams, certain areas of the brain, such as the prefrontal cortex, that involve self-awareness and thought evaluation show increased activity.
Studies have shown...
Studies have shown...
156
01:27Restless Leg Syndrome and Night Terrors
196
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
196
01:26Psychosis: Goals of Pharmacotherapy
158
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
158